Preparation of a cell concentrate from a physiological solution
View Patent ↗The present invention is directed to methods and compositions regarding the preparation of an cell concentrate, such as, for example, an osteogenic cell concentrate, from a physiological solution, such as bone marrow aspirate, blood, or a mixture thereof. In specific embodiments, the invention provides methods and compositions utilizing two physiological solution-processing techniques, particularly in a point of care environment, wherein centrifugation is not employed.
1. A method of preparing a cell concentrate comprising the steps of:
providing a physiological fluid which has not been previously subjected to centrifugation and which comprises platelets, plasma, nucleated cells and red blood cells,
combining a hypotonic fluid with the physiological fluid, the hypotonic fluid being in an amount which does not cause the cells to lyse in the physiological fluid/hypotonic fluid combination,
subjecting the combined physiological fluid/hypotonic fluid to a filter to produce a filter retentate and a permeate fluid, wherein said filter retentate comprises platelets and nucleated cells per unit volume greater than in the physiological fluid and wherein said permeate fluid comprises plasma and red blood cells, and
removing the filter retentate from the filter to produce the cell concentrate.
2. The method of claim 1 , wherein the physiological fluid comprises bone marrow aspirate, blood, or a mixture thereof.
3. The method of claim 1 , wherein said nucleated cells comprise leukocytes, stem cells, connective tissue progenitor cells, osteoprogenitor cells, chondroprogenitor cells, or a mixture thereof.
4. The method of claim 1 , wherein the stem cells are mesenchymal stem cells, hematopoietic stem cells, or both.
5. The method of claim 1 , wherein the hypotonic fluid is water.
6. The method of claim 1 , wherein the hypotonic fluid comprises sodium chloride.
7. The method of claim 1 , further comprising delivering the filter retentate removed from the filter to a bone defect in an individual.
8. The method of claim 1 , wherein said method farther comprises the step of admixing a scaffold material to the filter retentate removed from the filter to produce a scaffold material/filter retentate mixture.
9. The method of claim 8 , further comprising the step of delivering the scaffold material/filter retentate mixture to a bone defect in an individual.
10. The method of claim 8 , wherein the scaffold material is comprised of a block, paste, dust, cement, powder, granule, putty, liquid, gel, solid, or a mixture thereof.
11. The method of claim 8 , wherein the scaffold material is comprised of a ceramic, a polymer, a metal, allografi bone, autografi bone, demineralized bone matrix, or a mixture thereof.
12. The method of claim 8 , wherein the scaffold material is biodegradable.
13. The method of claim 8 , wherein the scaffold material is osteoconductive, osteogenic, osteoinductive, or a combination thereof.
14. The method of claim 8 , wherein the scaffold material is comprised of synthetic material, natural material, or a combination thereof.
15. The method of claim 8 , said method further comprising the step of admixing a biological agent with the filter retentate removed from the filter, the scaffold material, or a combination thereof.
16. The method of claim 15 , wherein the biological agent admixed with the scaffold material is further defined as the biological agent being comprised on the scaffold material, in the scaffold material, or both.
17. The method of claim 8 , further comprising the step of admixing a clotting initiator with the scaffold material/filter retentate mixture, the scaffold material, or both.
18. The method of claim 1 , wherein the filter retentate removed from the filter is subjected to at least one further processing step.
19. A method of preparing a cell concentrate comprising the steps of:
providing a physiological fluid which has not been previously subjected to centrifugation and which comprises platelets, plasma, nucleated cells and red blood cells,
combining a hypotonic fluid with the physiological fluid, the hypotonic fluid being in an amount which does not cause the cells to lyse in the physiological fluid/hypotonic fluid combination,
subjecting the combined physiological fluid/hypotonic fluid to a leukocyte reduction filter to produce a filter retentate and a permeate fluid, wherein said filter retentate comprises platelets and nucleated cells per unit volume greater than in the physiological fluid and wherein said permeate fluid comprises plasma and red blood cells, and
removing the filter retentate from the filter to produce the cell concentrate.